Novo Nordisk Foundation grants EUR 300m to new research center

The Novo Nordisk Foundation's biggest research center investment to date, a sum of EUR 300m, will enable future stem cell research. The grant supports the dream of curing chronic diseases, says Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.
Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH
Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH
by ANDREAS LØNSTRUP, translated by daniel pedersen

An investment of EUR 300m over ten years has been granted to a new international stem cell research center, dubbed Renew – the sum is the biggest grant that the Novo Nordisk Foundation has ever given to a research center, Danish media Berlingske reports.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading